JANAY TAYLOR: Open Payments
NPI 1952622391 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 13 payments from 5 companies in 2025. Trend: 2023 $434 · 2024 $272 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $303 |
| Indivior Inc. | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $36 |
Products named: Biktarvy, SUBLOCADE, ABILIFY MAINTENA, ABILIFY ASIMTUFII, Epclusa, VIVITROL, LYBALVI.
Industry payments across MD — which companies pay providers there.
